ArticleLipids in health and disease2024

Effects of Bifidobacterium and rosuvastatin on metabolic-associated fatty liver disease via the gut-liver axis.

Xue Ran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.